Pharmaceutical
Summary of Consolidated Financial Results for the First Quarter of FY2026
Summary of Consolidated Financial Results for the First Quarter of FY2026
About this update from Aska Pharmaceutical Holdings Co., Ltd.
Aska Pharmaceutical Holdings Co., Ltd. (4886) Press ReleaseView Attachment
View stock analysis, news, and events for Aska Pharmaceutical Holdings Co., Ltd.